1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of FMOD mRNA CTD PMID:21058326 17beta-estradiol decreases expression ISO RGD:733886 6480464 Estradiol results in decreased expression of FMOD mRNA CTD PMID:12469912 17beta-estradiol multiple interactions ISO RGD:1353289 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of FMOD mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1353289 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1353289 6480464 Tetrachlorodibenzodioxin results in increased expression of FMOD mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FMOD mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FMOD mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733886 6480464 Tetrachlorodibenzodioxin results in decreased expression of FMOD mRNA CTD PMID:33956508 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:733886 6480464 tetrabromobisphenol A results in decreased expression of FMOD mRNA CTD PMID:25172293 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1353289 6480464 tetrabromobisphenol A results in increased expression of FMOD protein CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1353289 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FMOD mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FMOD mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:733886 6480464 Methylcholanthrene results in decreased expression of FMOD mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO RGD:733886 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FMOD mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:733886 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of FMOD gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO RGD:733886 6480464 Fenretinide results in increased expression of FMOD mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:733886 6480464 Fenretinide results in decreased expression of FMOD mRNA CTD PMID:28973697 5-fluorouracil multiple interactions ISO RGD:1353289 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of FMOD mRNA] CTD PMID:15016801 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FMOD mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FMOD mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:1353289 6480464 Aflatoxin B1 results in increased methylation of FMOD gene CTD PMID:27153756 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FMOD mRNA CTD PMID:16483693 arsenous acid decreases expression ISO RGD:1353289 6480464 Arsenic Trioxide results in decreased expression of FMOD mRNA CTD PMID:26705709 benzo[a]pyrene decreases expression ISO RGD:733886 6480464 Benzo(a)pyrene results in decreased expression of FMOD mRNA CTD PMID:20713471 benzo[a]pyrene increases methylation ISO RGD:1353289 6480464 Benzo(a)pyrene results in increased methylation of FMOD exon, Benzo(a)pyrene results in increased methylation of FMOD promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1353289 6480464 Benzo(a)pyrene results in increased expression of FMOD mRNA CTD PMID:21871943 , PMID:22316170 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FMOD mRNA CTD PMID:25181051 more ... bisphenol A decreases expression ISO RGD:1353289 6480464 bisphenol A results in decreased expression of FMOD protein CTD PMID:31675489 bisphenol A increases expression ISO RGD:733886 6480464 bisphenol A results in increased expression of FMOD mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A multiple interactions ISO RGD:1353289 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FMOD gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FMOD mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A decreases expression ISO RGD:733886 6480464 bisphenol A results in decreased expression of FMOD mRNA CTD PMID:25594700 bisphenol F multiple interactions ISO RGD:1353289 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FMOD mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:733886 6480464 bisphenol F results in increased expression of FMOD mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1353289 6480464 butyraldehyde results in increased expression of FMOD mRNA CTD PMID:26079696 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of FMOD mRNA CTD PMID:20349343 carbon nanotube decreases expression ISO RGD:733886 6480464 Nanotubes, Carbon results in decreased expression of FMOD mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1353289 6480464 CGP 52608 promotes the reaction [RORA protein binds to FMOD gene] CTD PMID:28238834 chlordecone affects expression ISO RGD:733886 6480464 Chlordecone affects the expression of FMOD mRNA CTD PMID:33711761 cisplatin affects response to substance ISO RGD:1353289 6480464 FMOD protein affects the susceptibility to Cisplatin CTD PMID:16217747 cobalt atom multiple interactions ISO RGD:1353289 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of FMOD mRNA CTD PMID:18078969 crocidolite asbestos increases expression ISO RGD:733886 6480464 Asbestos, Crocidolite results in increased expression of FMOD mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FMOD mRNA CTD PMID:26577399 decabromodiphenyl ether increases expression ISO RGD:1353289 6480464 decabromobiphenyl ether results in increased expression of FMOD protein CTD PMID:31675489 deoxynivalenol decreases expression ISO RGD:1353289 6480464 deoxynivalenol results in decreased expression of FMOD mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:1353289 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FMOD mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FMOD mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:733886 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMOD mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:1353289 6480464 Arsenic Trioxide results in decreased expression of FMOD mRNA CTD PMID:26705709 diazepam decreases expression ISO RGD:1353289 6480464 Diazepam results in decreased expression of FMOD mRNA CTD PMID:19114084 diclofenac decreases expression ISO RGD:733886 6480464 Diclofenac results in decreased expression of FMOD mRNA CTD PMID:26934552 diethylstilbestrol decreases expression ISO RGD:733886 6480464 Diethylstilbestrol results in decreased expression of FMOD mRNA CTD PMID:15171707 dioxygen multiple interactions ISO RGD:733886 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMOD mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of FMOD mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:1353289 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMOD mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733886 6480464 Doxorubicin results in decreased expression of FMOD mRNA CTD PMID:19073829 doxorubicin affects expression ISO RGD:1353289 6480464 Doxorubicin affects the expression of FMOD mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1353289 6480464 entinostat results in increased expression of FMOD mRNA CTD PMID:27188386 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of FMOD mRNA CTD PMID:17033635 fulvestrant multiple interactions ISO RGD:1353289 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FMOD gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of FMOD mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FMOD mRNA CTD PMID:22061828 , PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of FMOD mRNA CTD PMID:24915197 glycidol increases expression EXP 6480464 glycidol results in increased expression of FMOD mRNA CTD PMID:24395379 hydrogen peroxide affects expression ISO RGD:1353289 6480464 Hydrogen Peroxide affects the expression of FMOD mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1353289 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FMOD mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FMOD mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:733886 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FMOD mRNA CTD PMID:36331819 methotrexate affects response to substance ISO RGD:1353289 6480464 FMOD protein affects the susceptibility to Methotrexate CTD PMID:16217747 monosodium L-glutamate increases expression ISO RGD:733886 6480464 Sodium Glutamate results in increased expression of FMOD mRNA CTD PMID:19001666 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FMOD mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of FMOD mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:733886 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FMOD mRNA CTD PMID:36331819 phenytoin decreases expression ISO RGD:1353289 6480464 Phenytoin results in decreased expression of FMOD mRNA CTD PMID:14741686 propanal increases expression ISO RGD:1353289 6480464 propionaldehyde results in increased expression of FMOD mRNA CTD PMID:26079696 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FMOD mRNA CTD PMID:27900601 SB 431542 multiple interactions ISO RGD:1353289 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMOD mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1353289 6480464 Silicon Dioxide analog results in decreased expression of FMOD mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:733886 6480464 Silver results in decreased expression of FMOD mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:733886 6480464 Silver results in decreased expression of FMOD mRNA CTD PMID:27131904 sodium fluoride decreases expression ISO RGD:733886 6480464 Sodium Fluoride results in decreased expression of FMOD protein CTD PMID:28918527 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of FMOD protein CTD PMID:29653260 T-2 toxin decreases expression ISO RGD:1353289 6480464 T-2 Toxin results in decreased expression of FMOD mRNA CTD PMID:31863870 tetrachloromethane increases expression ISO RGD:733886 6480464 Carbon Tetrachloride results in increased expression of FMOD mRNA CTD PMID:17484886 titanium dioxide affects expression ISO RGD:733886 6480464 titanium dioxide affects the expression of FMOD mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:733886 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMOD mRNA CTD PMID:29950665 titanium dioxide decreases expression ISO RGD:733886 6480464 titanium dioxide results in decreased expression of FMOD mRNA CTD PMID:29264374 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of FMOD gene CTD PMID:27618143 trimellitic anhydride decreases expression ISO RGD:733886 6480464 trimellitic anhydride results in decreased expression of FMOD mRNA CTD PMID:19042947 Tungsten carbide multiple interactions ISO RGD:1353289 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of FMOD mRNA CTD PMID:18078969 urethane decreases expression ISO RGD:1353289 6480464 Urethane results in decreased expression of FMOD mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1353289 6480464 Valproic Acid affects the expression of FMOD mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1353289 6480464 Valproic Acid results in increased expression of FMOD mRNA CTD PMID:26272509 , PMID:27188386 valproic acid multiple interactions ISO RGD:1353289 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMOD mRNA CTD PMID:27188386